OncoImmunology (Jun 2017)

Tumor-priming converts NK cells to memory-like NK cells

  • Marina Pal,
  • Lisa Schwab,
  • Anastasiya Yermakova,
  • Emily M. Mace,
  • Rainer Claus,
  • Ann-Christin Krahl,
  • Jeanette Woiterski,
  • Udo F. Hartwig,
  • Jordan S. Orange,
  • Rupert Handgretinger,
  • Maya C. André

DOI
https://doi.org/10.1080/2162402X.2017.1317411
Journal volume & issue
Vol. 6, no. 6

Abstract

Read online

Fascinating earlier evidence suggests an intrinsic capacity of human natural killer (NK) cells to acquire adaptive immune features in the context of cytomegalovirus (CMV) infection or pro-inflammatory cytokine stimulation. Since the role of memory NK cells in cancer has so far remained elusive and adoptive NK cell transfer in relapsing pediatric acute B cell precursor leukemia (BCP-ALL) patients awaits improvement, we asked the question whether tumor-priming could promote the generation of memory NK cells with enhanced graft-vs.-leukemia (GvL) reactivity. Here, we provide substantial evidence that priming of naive human NK cells with pediatric acute B cell leukemia or acute myeloid leukemia specimens induces a functional conversion to tumor-induced memory-like (TIML)-NK cells displaying a heightened tumor-specific cytotoxicity and enhanced perforin synthesis. Cell cycles analyses reveal that tumor-priming sustainably alters the balance between NK cell activation and apoptosis in favor of survival. In addition, gene expression patterns differ between TIML- and cytokine-induced memory-like (CIML)-NK cells with the magnitude of regulated genes being distinctly higher in TIML-NK cells. As such, the tumor-induced conversion of NK cells triggers the emergence of a so far unacknowledged NK cell differentiation stage that might promote GvL effects in the context of adoptive cell transfer.

Keywords